# ClinicalTrials.gov record NCT04467983

> PeptideScanner retained ClinicalTrials.gov record NCT04467983 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-08, and PeptideScanner's reviewed identity mapping was abaloparatide.

- Evidence object: `story:clinicaltrials-gov-nct04467983-abaloparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04467983-abaloparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04467983-abaloparatide-v1.json
- Content SHA-256: `3de44c11abd75eacaafe2033f3a76020154cab54364f6cddcd76d75429217e5e`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04467983 ([`ctg-observation-nct04467983-2026-06-08-2545958f752a`](#source-ctg-observation-nct04467983-2026-06-08-2545958f752a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04467983 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-08, and PeptideScanner's reviewed identity mapping was abaloparatide. ([`ctg-observation-nct04467983-2026-06-08-2545958f752a`](#source-ctg-observation-nct04467983-2026-06-08-2545958f752a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04467983 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-08, and PeptideScanner's reviewed identity mapping was abaloparatide. ([`ctg-observation-nct04467983-2026-06-08-2545958f752a`](#source-ctg-observation-nct04467983-2026-06-08-2545958f752a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04467983-2026-06-08-2545958f752a`](#source-ctg-observation-nct04467983-2026-06-08-2545958f752a))

## Sources

<a id="source-ctg-observation-nct04467983-2026-06-08-2545958f752a"></a>
- **ClinicalTrials.gov record NCT04467983 · retained source version 2026-06-08:2545958f752a55b8b5dde100012de94fab7f2feb82687c062a0e25a12cf82906** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04467983) (`ctg-observation-nct04467983-2026-06-08-2545958f752a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04467983." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04467983-abaloparatide-v1.json SHA-256: 3de44c11abd75eacaafe2033f3a76020154cab54364f6cddcd76d75429217e5e.